• Develop an innovative procedure that educates participants about clinical research trials to reduce TM; and
• Test this innovative procedure in a hypothetical
clinical research trial to reduce TM without reducing study enrollment rates.
Methodology/Design
Study participants were randomly divided into two groups: an experimental group and a control group. Members of each group watched a narrated educational Power Point presentation about the hypothetical clinical research trial they were being asked to pretend to consent to. Members of the experimental group watched an additional presentation explaining exactly what a clinical research trial is, and how participating in a clinical research trail may be different than receiving conventional care.
After viewing the presentation(s), all study participants completed a survey that included background information, a measure of TM, and the participant's decision about whether they would agree to participate in the hypothetical clinical research trial they learned about during the presentation(s).
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History/Background
"Therapeutic misconception" (TM) describes when a clinical research trial participant fails to understand the difference between participating in a clinical trial versus receiving conventional treatment, i.e., treatment as usual. 1-2 Individuals experiencing TM mistakenly assume that by enrolling in a clinical research trial they will receive the latest experimental treatment, without understanding the differences including that they will be randomly assigned to either an experimental or a conventional control group.
1-2 Patients in conventional treatment receive personalized treatment plans, which allow for treatment changes that are best for a particular patient. Conversely, patients in clinical trials receive treatment controlled by a strict clinical research protocol.
Preliminary Outcomes/Future Impact
Preliminary analyses show no significant differences between the groups regarding their decision about whether or not to participate in the hypothetical clinical research trial. However, results indicate a statistically significant difference in TM scale scores, suggesting experimental group participants were less likely to experience TM. This suggests that including a brief educational presentation about the purpose, nature, and design of clinical research trials during the informed consent process does not negatively impact recruitment, and can help reduce TM.
